Unknown

Dataset Information

0

Catalpol protects synaptic proteins from beta-amyloid induced neuron injury and improves cognitive functions in aged rats.


ABSTRACT: Synapse loss is one of the common factors contributing to cognitive disorders, such as Alzheimer's disease (AD), which is manifested by the impairment of basic cognitive functions including memory processing, perception, problem solving, and language. The current therapies for patients with cognitive disorders are mainly palliative; thus, regimens preventing and/or delaying dementia progression are urgently needed. In this study, we evaluated the effects of catalpol, isolated from traditional Chinese medicine Rehmannia glutinosa, on synaptic plasticity in aged rat models. We found that catalpol markedly improved the cognitive function of aged male Sprague-Dawley rats and simultaneously increased the expression of synaptic proteins (dynamin 1, PSD-95, and synaptophysin) in the cerebral cortex and hippocampus, respectively. In beta-amyloid (A?) injured primary rat's cortical neuron, catalpol did not increase the viability of neuron but extended the length of microtubule-associated protein 2 (MAP-2) positive neurites and reversed the suppressive effects on expression of synaptic proteins induced by A?. Additionally, the effects of catalpol on stimulating the growth of MAP-2 positive neurites and the expression of synaptic proteins were diminished by a PKC inhibitor, bisindolylmaleimide I, suggesting that PKC may be implicated in catalpol's function of preventing the neurodegeneration induced by A?. Altogether, our study indicates that catalpol could be a potential disease-modifying drug for cognitive disorders such as AD.

SUBMITTER: Xia Z 

PROVIDER: S-EPMC5642480 | biostudies-literature | 2017 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Catalpol protects synaptic proteins from beta-amyloid induced neuron injury and improves cognitive functions in aged rats.

Xia Zhiming Z   Wang Fengfei F   Zhou Shuang S   Zhang Rui R   Wang Fushun F   Huang Jason H JH   Wu Erxi E   Zhang Yongfang Y   Hu Yaer Y  

Oncotarget 20170517 41


Synapse loss is one of the common factors contributing to cognitive disorders, such as Alzheimer's disease (AD), which is manifested by the impairment of basic cognitive functions including memory processing, perception, problem solving, and language. The current therapies for patients with cognitive disorders are mainly palliative; thus, regimens preventing and/or delaying dementia progression are urgently needed. In this study, we evaluated the effects of catalpol, isolated from traditional Ch  ...[more]

Similar Datasets

| S-EPMC4182554 | biostudies-other
| S-EPMC7897582 | biostudies-literature
| S-EPMC8604688 | biostudies-literature
| S-EPMC5839766 | biostudies-literature
| S-EPMC2276592 | biostudies-other
| S-EPMC6875068 | biostudies-literature
| S-EPMC8278544 | biostudies-literature
| S-EPMC4857086 | biostudies-other
2014-09-23 | E-GEOD-61326 | biostudies-arrayexpress
| S-EPMC10497847 | biostudies-literature